Zuletzt aktualisiert: August 17, 2026
Autismus-Spektrum-Störung (ASD) ichs a complex neurodevelopmental condition characterized by impairments in social communication, sich wiederholende Verhaltensweisen, und eingeschränkte Interessen. Although the exact etiology remains unclear, research points to a combination of genetic, Umwelt, immunological, and neuroinflammatory factors. Recent clinical and experimental studies have highlighted the therapeutic potential of Stammzelltherapie in alleviating core symptoms of autism, offering hope through a multi-level biological impact.
Biopathological Improvements
One of the central pathological features observed in individuals with ASD is chronic neuroinflammation. Microglial activation, elevated pro-inflammatory cytokines, and astroglial dysfunction contribute to disrupted neural connectivity and synaptic plasticity. Stammzelltherapie, particularly using mesenchymale Stammzellen (MSCs) exerts a strong anti-inflammatory effect. MSCs secrete anti-inflammatory cytokines (wie IL-10 und TGF-β) and reduce the levels of pro-inflammatory markers (wie TNF-α und IL-6), thereby restoring a healthier neuroimmune environment.
Zusätzlich, ASD is often associated with hypoperfusion — decreased blood flow in specific brain areas. Stem cells stimulate Angiogenese by releasing vascular endothelial growth factor (VEGF), enhancing cerebral blood flow, Oxygenierung, and nutrient delivery, which supports better cognitive and behavioral outcomes.
Biochemische Mechanismen
On a biochemical level, oxidative stress plays a significant role in ASD pathology. Individuals with autism frequently exhibit increased reactive oxygen species (ROS) and decreased levels of antioxidants such as glutathione. Stem cell therapy improves the oxidative balance by promoting antioxidant enzyme production (Z.B., superoxide dismutase and catalase) and reducing ROS levels.
Darüber hinaus, abnormal mitochondrial function is a common finding in ASD, contributing to impaired cellular energy metabolism. Stem cells enhance mitochondrial activity by transferring healthy mitochondria through tunneling nanotubes or releasing mitochondrial DNA and proteins that repair damaged mitochondria. This leads to increased ATP production and improved neuronal function.
Neurotrophic factors, essential for synaptic growth and neuroplasticity, are also upregulated after stem cell therapy. Elevated brain-derived neurotrophic factor (BDNF) levels facilitate better synaptic transmission, Lernen, and memory formation, key areas often impaired in autism.
Cellular Level Changes
At the cellular level, stem cells act via both parakrine Signalübertragung and direct cellular replacement mechanisms. Although actual integration of transplanted cells into neural circuits remains limited, their secreted factors significantly modulate the behavior of resident cells. Microglial cells shift from a pro-inflammatory (M1) to an anti-inflammatory (M2) Phänotyp, promoting tissue repair and reducing neurotoxicity.
Astrocytes, critical for maintaining the blood-brain barrier and synaptic regulation, also regain normal functionality under the influence of stem cell secretomes. This leads to improved synaptic homeostasis and stabilization of neural networks.
Außerdem, stem cells enhance the proliferation of endogenous neural stem/progenitor cells and support oligodendrocyte maturation, promoting myelination. Myelin deficits, implicated in ASD, can disrupt the speed and fidelity of neural communication. Daher, improved myelination results in more efficient brain signaling and cognitive processing.
Abschluss
Zusammenfassend, stem cell therapy offers a multifaceted approach to treating autism, addressing its complex pathophysiology at biopathological, biochemical, and cellular levels. Durch die Reduzierung der Neuroinflammation, enhancing mitochondrial function, correcting oxidative stress, Förderung der Angiogenese, and supporting synaptic remodeling, stem cell treatments pave the way for significant improvements in social behavior, Kommunikation, und Lebensqualität für Menschen mit ASD.
Wissenschaftliche Fallbesprechung
Möchten Sie verstehen, ob aktuelle klinische Programme, aktuelle Forschungsentwicklungen, oder neue Ansätze können sein relevant für Ihre individuelle Situation?
Senden Sie Ihre Frage an unser wissenschaftliches Team. Der Hauptsitz von NBScience im Vereinigten Königreich koordiniert Anfragen im internationalen Netzwerk medizinischer Zentren, Wissenschaftler, und spezialisierte Berater.
- Überprüfung der von Ihnen bereitgestellten Informationen
- Relevante Informationen zu Forschung und klinischen Programmen
- Eine klare Antwort, die sich auf Ihre Situation konzentriert
Keine Verpflichtung. Ihre Frage wird vertraulich behandelt.
Nur Bildungs- und Forschungsinformationen. Dieser Dienst funktioniert nicht stellen eine medizinische Beratung dar, Diagnose, Rezept, oder eine personalisierte Behandlungsempfehlung.
